(R)-methyl 2-((R)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate, 95%, 250mg

3-Bromoimidazo[1,2-b]pyridazin-6-ylamine, 95.0%, 1g

4-Phenyldibenzothiophene>98.0%(GC)5g

1-(tert-Butoxycarbonyl)-3,3-difluoropiperidine-4-carboxylic acid, 95.0%, 100mg

5-Fluoro-1H-benzo[d][1,3]oxazine-2,4-dione, 95.0%, 5g

2-Methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 97%, 250mg

4-tert-Butyl-4'-fluorobenzhydrol, 97.0%, 5g

3-OXABICYCLO[3.1.0]HEXAN-6-YLMETHANOL, 95.0%, 250mg

1-METHYL-1H-INDAZOLE-7-CARBOXYLIC ACID, 95%, 1g

(Z-Cys-OH)2, 97%, 500g

2-Propenoic acid, 3-[4-[(1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)-1-buten-1-yl]phenyl]-, (2E)-, 25mg

Colonne capillaire GC ROTI®Cap-WAX, 25 m, 0,32 mm, 0,50 µm, 1 pièce(s)

Sulfate de lutétium hydraté 99,999% 2 g